Partner(s)
Dionamix Scientific Inc.My research in optimizing lipid nanoparticle formulations and developing next-generation drug delivery platforms is advancing translational health innovation in British Columbia. By integrating polymer and peptide-functionalized nanoparticles for extrahepatic delivery, and by establishing automated, scalable formulation platforms, my work accelerates the development of more effective and commercially relevant therapies. Through collaborations with both academic and industry partners, these efforts strengthen BC’s capacity for cutting-edge nanomedicine research, foster interdisciplinary training, and contribute to a vibrant ecosystem for health innovation in the province.
My research in lipid nanoparticle optimization and functionalized drug delivery systems directly addresses pressing health priorities in British Columbia by enabling safer, more effective, and targeted therapies for conditions that are difficult to treat, including cancer and systemic diseases requiring extrahepatic delivery. By integrating automated formulation platforms and fostering academic–industry collaboration, my work accelerates translational research, enhances BC’s capacity for innovative therapeutics, and strengthens the province’s leadership in developing scalable, next-generation health technologies.